Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Placebo can bring emotional relief

17.06.2005


Just as placebos have been shown to bring relief from pain, researchers have now found that they can affect emotion, alleviating the impact of unpleasant experiences. In an article in the June 16, 2005, issue of Neuron, researchers led by Predrag Petrovic of the Karolinska Institutet show that, in relieving anxiety, placebo treatment affects the same basic modulatory circuitry in the brain as it does for relieving pain.



In their experiments, the researchers tested the effect of placebo treatment on volunteer subjects’ ratings of unpleasant pictures, such as images of mutilated bodies. Other researchers had shown that people’s expectation of pain relief plays a major role in the effectiveness of placebos. So, in their experiments, the researchers first induced such an expectation in the subjects by administering an antianxiety drug to reduce the subjects’ unpleasant perception of the pictures. They then administered an antidote to the drug, telling the subjects that it would restore the unpleasant perception.

In tests the following day, the subjects were told they would receive the same drugs. But instead, they received a saline solution as a placebo when they saw the pictures. The subjects’ brains were also scanned during these experiments using functional magnetic resonance imaging (fMRI). This scanning technique uses harmless magnetic fields and radio waves to measure blood flow in brain regions, which reflects brain activity.


The researchers found that the placebo reduced the subjects’ ratings of the unpleasant pictures by about 29%. Importantly, the fMRI scans showed that the placebo reduced activity in the brain’s emotional centers, and this reduction correlated with a subject’s amount of reduction in the rated unpleasantness of the pictures. That is, the subjects who reported the largest placebo response also showed the largest decrease in activity in the emotional centers.

Also importantly, the placebo increased brain activity in the same “modulatory network” whose activity is increased when placebos have been used to relieve pain.

The researchers found that, as in placebo treatment for pain, expectation played a major role in effectiveness. Those subjects who expected the largest effect—as measured by the effect they reported from the real antianxiety drug the previous day—showed the largest changes in activity in the emotional and modulatory areas.

“The present data demonstrate that emotional experience may be modulated through a placebo treatment in a similar manner as has been previously reported for pain perception,” concluded Petrovic and his colleagues. They wrote that the study “demonstrated that very similar mechanisms are involved in the placebo response of emotional stimuli and in placebo analgesia, thereby generalizing the concept of placebo and its associated underlying neural processes.” They also concluded that the placebo effect can be thought of “as a general process of modulation induced by the subjects’ expectations, possibly using specific modulating systems.”

The researchers include Predrag Petrovic, Thomas Dietrich, Peter Fransson, Jesper Andersson, Katrina Carlsson, and Martin Ingvar of the Cognitive Neurophysiology Research Group R2-01 of the Department of Clinical Neuroscience at Karolinska Institutet in Stockholm, Sweden. This study was supported by grants from the Swedish Medical Research Council, Förenade Liv, the Karolinska Institute, the Swedish Medical Association, the Knut and Alice Wallenberg foundation, and the Petrus and Augusta Hedlunds foundation.

Dr Predrag Petrovic | alfa
Further information:
http://info.ki.se/article_en.html?ID=3942

More articles from Health and Medicine:

nachricht Speed data for the brain’s navigation system
06.12.2016 | Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE)

nachricht Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Simple processing technique could cut cost of organic PV and wearable electronics

06.12.2016 | Materials Sciences

3-D printed kidney phantoms aid nuclear medicine dosing calibration

06.12.2016 | Medical Engineering

Robot on demand: Mobile machining of aircraft components with high precision

06.12.2016 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>